<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02879825</url>
  </required_header>
  <id_info>
    <org_study_id>2016-A00954-47</org_study_id>
    <nct_id>NCT02879825</nct_id>
  </id_info>
  <brief_title>Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse)</brief_title>
  <acronym>STAMP</acronym>
  <official_title>Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mitral valve prolapse (MVP) is a frequent affection of the mitral valve or its sub-valvular
      apparatus with a prevalence of 2-3% in the general population. This valvular disease is
      generally considered as benign, but may at term evolve toward mitral valve regurgitation of
      various severity and/or arrhythmia.

      Mitral valve prolapse is routinely diagnosed using transthoracic echocardiography and only
      patients with significant mitral regurgitation will undergo subsequent examination (24-hour
      external loop recording, exercise ECG, cardiac MRI) and a close follow-up.

      External loop recording and exercise ECG have an interest in the identification of patients
      presenting with arrhythmic complications, such as premature ventricular contractions, and in
      the global evaluation of hemodynamic consequences of the mitral regurgitation.

      More recently, detection of myocardial fibrosis among patients with MVP and severe
      ventricular arrhythmia has been identified. Fibrosis could evolve independently of the
      valvular regurgitation's severity and could be a substrate (myocardial scar) leading to
      ventricular arrhythmia. However, no study has specifically characterized myocardial lesions
      among patients with MVP and none, or not significant, mitral regurgitation. Using cardiac
      magnetic resonance imaging (MRI), gold standard technique in myocardial imaging and
      characterization, and echocardiography, particularly speckle-tracking imaging, identification
      of static (fibrosis) and/or dynamic (ventricular systolic deformation patterns using
      speckle-tracking strain) myocardial lesions.

      Identification of patients with impaired deformation patterns, fibrosis or with premature
      ventricular contractions may isolate a sub-group of patients with a higher risk of severe
      ventricular arrhythmia for whom a closer follow-up could be justified.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2016</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of ventricular arrythmia (premature ventricular contraction or tachycardia)</measure>
    <time_frame>Within 15 days</time_frame>
    <description>Occurrence of any ventricular arrythmia on external loop recording or exercise ECG</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evidence of myocardial fibrosis on cardiac MRI</measure>
    <time_frame>Within 15 days</time_frame>
    <description>Visualisation of any late gadolinium enhancement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Estimation of mitral regurgitation severity on echocardiography</measure>
    <time_frame>At inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description and evaluation of ventricular myocardial deformation patterns</measure>
    <time_frame>Within 15 days</time_frame>
    <description>Comparison of deformation patterns using speckle-tracking echocardiography and strain in cardiac MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparative evaluation of mitral regurgitation using echocardiography and cardiac MRI</measure>
    <time_frame>Within 15 days</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">230</enrollment>
  <condition>Mitral Valve Prolapse</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mitral valve prolapse without mitral regurgitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mitral valve prolapse with trivial mitral regurgitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mitral valve prolapse with moderate or mild mitral regurgitation and asymptomatic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mitral valve prolapse with severe mitral regurgitation or symptomatic</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac MRI</intervention_name>
    <description>Group-A patients, with mitral valve prolapse but no mitral regurgitation, will undergo specifically for research purposes a cardiac MRI, 24-hour external loop recording and exercise ECG on top of regular echocardiography evaluation.
Realization of these examinations will be performed according to recommendations for patients with mitral regurgitation (groups B, C and D)</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group D</arm_group_label>
    <other_name>24-hour external loop recording</other_name>
    <other_name>Exercise ECG</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mitral valve prolapse diagnosed in echocardiography

          -  Signed written consent

          -  Affiliation to social security

          -  No contraindication to MRI or exercise ECG

          -  Age above 18

        Exclusion Criteria:

          -  Mitral valve prolapse with severe regurgitation and instable hemodynamic state
             requiring urgent surgery

          -  Prior MRI with contrast within the last month

          -  Prior diagnosis of primary cardiomyopathy potentially responsible for myocardial
             fibrosis

          -  Contraindication to exercise ECG: severe handicap, poor physical capacity

          -  Contraindication to MRI: implantable device, claustrophobia, metal debris

          -  Renal insufficiency with creatinine clearance &lt;30 ml/min or prior serious side effect
             related to infusion of a magnetic contrast agent

          -  Pregnant or breast-feeding women

          -  Minors &lt;18 years old

          -  Mental illness or incapacity with incapacity to obtain informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clement VENNER, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, Nancy University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clement VENNER, MD, MSc</last_name>
    <phone>+33383157352</phone>
    <email>c.venner@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Olivier HUTTIN, MD, MSc</last_name>
    <phone>+33383157355</phone>
    <email>o.huttin@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nancy University Hospital, Department of Cardiology</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clement VENNER, MD, MSc</last_name>
      <phone>+33383157352</phone>
      <email>c.venner@chru-nancy.fr</email>
    </contact>
    <contact_backup>
      <last_name>Olivier HUTTIN, MD, MSc</last_name>
      <phone>+33383157355</phone>
      <email>o.huttin@chru-nancy.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Basso C, Perazzolo Marra M, Rizzo S, De Lazzari M, Giorgi B, Cipriani A, Frigo AC, Rigato I, Migliore F, Pilichou K, Bertaglia E, Cacciavillani L, Bauce B, Corrado D, Thiene G, Iliceto S. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death. Circulation. 2015 Aug 18;132(7):556-66. doi: 10.1161/CIRCULATIONAHA.115.016291. Epub 2015 Jul 9.</citation>
    <PMID>26160859</PMID>
  </reference>
  <reference>
    <citation>Huttin O, Pierre S, Venner C, Voilliot D, Sellal JM, Aliot E, Sadoul N, Juillière Y, Selton-Suty C. Interactions between mitral valve and left ventricle analysed by 2D speckle tracking in patients with mitral valve prolapse: one more piece to the puzzle. Eur Heart J Cardiovasc Imaging. 2017 Mar 1;18(3):323-331. doi: 10.1093/ehjci/jew075.</citation>
    <PMID>27099279</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2016</study_first_submitted>
  <study_first_submitted_qc>August 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2016</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Clément VENNER</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Ventricular Premature Complexes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Mitral Valve Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

